Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

G J LaRosa1, J P Davide, K Weinhold

  • 1Repligen Corporation, Cambridge, MA 02139.

Science (New York, N.Y.)
|August 24, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idebenone: a new antioxidant - Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants.

Journal of cosmetic dermatology·2006
Same author

Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.

Journal of cosmetic dermatology·2006
Same author

Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.

Developments in biologicals·2006
Same author

Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line.

Developments in biologicals·2006
Same author

Osteomyelitis complicating three types of traumatic hand wound.

Journal of wound care·2005
Same author

An evaluation of the efficacy of Aqualox for microbiological control of industrial cooling tower systems.

The Journal of hospital infection·2002
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

The principal neutralizing determinant (PND) of human immunodeficiency virus (HIV-1) shows conserved sequences, suggesting constraints on its variability. This finding is crucial for developing effective HIV vaccines targeting a majority of viral isolates.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • The principal neutralizing determinant (PND) is a key target on the HIV-1 envelope protein gp120.
  • Understanding PND variability is critical for effective HIV vaccine design.

Purpose of the Study:

  • To analyze the variability of the HIV-1 PND across different isolates.
  • To investigate constraints on PND variability and their implications for vaccine development.

Main Methods:

  • Sequence analysis of the PND from 245 HIV-1 isolates.
  • Neural network prediction of the PND's structural motif.
  • Antibody reactivity assays using sera from HIV-1 seropositive donors.

Main Results:

  • The PND exhibits higher conservation than previously thought, with 9 out of 14 positions conserved in over 80% of isolates.

Related Experiment Videos

  • Specific oligopeptide sequences and a predicted structural motif (beta strand--type II beta turn--beta strand--alpha helix) suggest constraints on PND variability.
  • Sera reacted more frequently with common PND sequences (65%) than with PNDs similar to HTLV-IIIB/LAV-1 strains (14%).

    • Conclusions:

    • HIV-1 PND variability is constrained, likely by structural and sequence requirements.
    • Vaccine immunogens based on consensus PND sequences are more likely to elicit broadly neutralizing antibodies.
    • This research informs the rational design of HIV vaccines for broader efficacy.